bioAffinity Technologies (BIAF) Competitors $1.37 -0.06 (-4.20%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BIAF vs. FORA, HGBL, ISPC, LUNA, JUNE, SGRP, VCSA, FLNT, EHGO, and LICNShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Forian (FORA), Heritage Global (HGBL), iSpecimen (ISPC), Luna Innovations (LUNA), Junee (JUNE), SPAR Group (SGRP), Vacasa (VCSA), Fluent (FLNT), Eshallgo (EHGO), and Lichen China (LICN). These companies are all part of the "business services" industry. bioAffinity Technologies vs. Forian Heritage Global iSpecimen Luna Innovations Junee SPAR Group Vacasa Fluent Eshallgo Lichen China Forian (NASDAQ:FORA) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, community ranking, media sentiment, valuation, risk, analyst recommendations and institutional ownership. Does the media prefer FORA or BIAF? In the previous week, Forian had 4 more articles in the media than bioAffinity Technologies. MarketBeat recorded 5 mentions for Forian and 1 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 1.08 beat Forian's score of -0.01 indicating that bioAffinity Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forian 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral bioAffinity Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in FORA or BIAF? Forian received 8 more outperform votes than bioAffinity Technologies when rated by MarketBeat users. However, 100.00% of users gave bioAffinity Technologies an outperform vote while only 90.00% of users gave Forian an outperform vote. CompanyUnderperformOutperformForianOutperform Votes990.00% Underperform Votes110.00%bioAffinity TechnologiesOutperform Votes1100.00% Underperform VotesNo Votes Which has higher valuation and earnings, FORA or BIAF? Forian has higher revenue and earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Forian, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioForian$20.37M3.12$1.56M$0.0540.80bioAffinity Technologies$2.53M7.27-$7.94M-$0.92-1.49 Which has more risk & volatility, FORA or BIAF? Forian has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 2.92, suggesting that its stock price is 192% more volatile than the S&P 500. Do insiders & institutionals believe in FORA or BIAF? 19.3% of Forian shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 31.3% of Forian shares are owned by insiders. Comparatively, 40.0% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is FORA or BIAF more profitable? Forian has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -120.76%. Forian's return on equity of 0.00% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets ForianN/A N/A N/A bioAffinity Technologies -120.76%-172.06%-106.72% Do analysts recommend FORA or BIAF? Forian currently has a consensus price target of $9.00, indicating a potential upside of 341.18%. bioAffinity Technologies has a consensus price target of $6.00, indicating a potential upside of 337.96%. Given Forian's higher probable upside, analysts clearly believe Forian is more favorable than bioAffinity Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Forian 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00bioAffinity Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryForian beats bioAffinity Technologies on 12 of the 17 factors compared between the two stocks. Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.40M$4.58B$5.40B$8.53BDividend YieldN/A1.71%5.15%4.14%P/E Ratio-1.4960.14113.7615.14Price / Sales7.2760.861,483.0493.53Price / CashN/A23.5039.7134.04Price / Book2.692.884.665.01Net Income-$7.94M$140.16M$119.06M$225.46M7 Day Performance-2.14%-1.54%0.79%0.37%1 Month Performance-27.51%-4.44%5.65%3.57%1 Year Performance11.38%30.94%36.80%29.42% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies1.9216 of 5 stars$1.37-4.2%$6.00+338.0%+7.0%$18.40M$2.53M-1.4910Short Interest ↑FORAForian2.2019 of 5 stars$2.08+1.5%$9.00+332.7%-16.7%$64.77M$20.37M20.8036Gap UpHGBLHeritage Global1.9167 of 5 stars$1.67-1.2%N/A-45.6%$62.36M$55.02M5.5782Upcoming EarningsShort Interest ↓News CoveragePositive NewsISPCiSpecimen1.1243 of 5 stars$4.73-10.2%N/A+561.0%$61.85M$10.51M-0.2260Upcoming EarningsNews CoverageLUNALuna Innovations2.0231 of 5 stars$1.81+1.7%$8.00+342.0%-70.9%$61.47M$109.50M-22.63337Analyst ForecastJUNEJuneeN/A$4.75+0.2%N/AN/A$60.39M$4.79M0.00N/AGap UpSGRPSPAR Group3.4459 of 5 stars$2.46+2.1%N/A+142.5%$59.86M$258.42M4.6424,288VCSAVacasa2.5409 of 5 stars$2.39-2.4%$9.13+281.8%-66.3%$53.97M$1.12B-0.086,400Upcoming EarningsNews CoverageFLNTFluent2.6449 of 5 stars$3.03-5.3%$4.00+32.0%+4.2%$51.12M$298.40M-0.80260Analyst ForecastEHGOEshallgoN/A$2.33+6.9%N/AN/A$50.65M$16.96M0.00128Gap UpLICNLichen ChinaN/A$1.84+1.1%N/A+68.2%$48.76M$41.93M0.00390Short Interest ↑News CoveragePositive News Related Companies and Tools Related Companies Forian Competitors Heritage Global Competitors iSpecimen Competitors Luna Innovations Competitors Junee Competitors SPAR Group Competitors Vacasa Competitors Fluent Competitors Eshallgo Competitors Lichen China Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BIAF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIAF Stock Alerts